Bluebird Stock Crashes To 7-Year Low After FDA Pauses Gene Therapy Test
Bluebird Bio (BLUE) said Monday the Food and Drug Administration paused one of its gene therapy studies due to safety concerns, and BLUE stock collapsed.
XThe drug isn’t approved in the U.S., though sells in Europe under the name Skysona. It treats a rare…
